Business Wire Feed
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
First FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2 Severe LAD-I is an ultra-rare, life-threatening pediatric genetic immunodeficiency characterized by recurrent infections and high early-childhood mortality without treatment FDA more...
Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD
First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate Phase III clinical trialsWILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Phase III OBERON and TITANIA trials in more...
Agenus to Host March 2026 Stakeholder Webcast Harnessing the Immune System to Advance BOT + BAL Across Tumor Types and Expand Patient Access
Webcast on Tuesday, March 31, 2026, at 4:30 p.m. ETLEXINGTON, Mass.--(BUSINESS WIRE)--$AGEN #BAL--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its March Stakeholder Webcast focused on continued progress of more...
Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine
Maternal-Fetal Medicine Specialists of Tennessee Provides Vital Care for Greater Nashville AreaFORT LAUDERDALE, Fla.--(BUSINESS WIRE)--$MD--Pediatrix® Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a more...
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
Alpha Cognition generated fourth quarter 2025 ZUNVEYL net product revenue of $2.5 million, contributing to full year 2025 total revenue of $10.2 million Fourth quarter bottles dispensed increased 62% quarter-over-quarter to 4,941, with December representing more...
HCA Healthcare, Inc. 1st Quarter 2026 Earnings Conference Call
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2026 Earnings Call When: Friday, April 24, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over more...
GetHealthy Launches Script, an AI-Enabled Platform Expanding Practitioner Commerce Beyond Supplements Across Seven Product Categories
New platform unifies clinical recommendations and multi-category lifestyle commerce with AI-assisted product discoveryAUSTIN, Texas--(BUSINESS WIRE)--GetHealthy, the infrastructure platform powering practitioner-led health commerce, today announced the launch of GetHealthy Script, an AI-enabled clinical scripting platform designed more...
Milken Institute’s 2026 Global Conference Convenes Changemakers in Los Angeles, May 3–6
At a defining moment for international stability, leaders will focus on solutions through open dialogue and cross-sector collaboration.LOS ANGELES--(BUSINESS WIRE)--The Milken Institute today announced the initial speaker lineup for the 2026 Global Conference, taking place more...
ImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBC Trial to Detect Clinically Meaningful Differences Between ANKTIVA® Plus BCG Versus BCG Alone; Supplemental BLA Submission on Track for 2026
The QUILT-2.005 randomized clinical trial is on track for final analysis and supplemental Biologics License Application (BLA) submission in 2026 for the BCG-naïve NMIBC carcinoma in situ with or without papillary indication with no additional more...
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced additional details for its Investor more...
Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced positive results today from the Phase 2 PANOVA-4 trial of Tumor Treating Fields (TTFields) therapy concomitant with atezolizumab (Tecentriq®), gemcitabine and nab-paclitaxel (gem/nab-pac) as a first-line treatment for metastatic more...
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne
Almirall advances scientific leadership in medical dermatology with new data across atopic dermatitis, psoriasis, actinic keratosis and acne, reinforcing its commitment to improving patient outcomes. More than 15 posters will be presented at the 2026 more...
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
Transaction accelerates Herbalife and Cristiano Ronaldo’s commitment to scale personalized nutrition and wellness globallyLOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced an agreement to acquire certain more...
Massive Gaps Uncovered for Diabetes Screening in Urgent Care, Research Shows
Data insights from UCP Merchant Medicine’s Intellivisit software suggest an abundance of missed opportunities for diabetes screening alongside growing urgent care usageNASHVILLE, Tenn.--(BUSINESS WIRE)--UCP Merchant Medicine, the leading provider of consulting services and clinical AI more...
Token Launches TokenCore Node: Setting a New Standard for Biometric Identity Assurance
Unveiled at RSA Conference 2026, the TokenCore Node brings cryptographic biometric identity assurance to air-gapped and classified environments – where no credential-based solution can follow.SAN FRANCISCO--(BUSINESS WIRE)--#Biometrics--Token, the biometric identity assurance company, today announced the more...
Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification
IdentiClone® Dx IGH is the first IVDR-certified assay for the detection of clonal immunoglobulin gene rearrangements in patients with suspected B-cell lymphoproliferative disease.SAN DIEGO--(BUSINESS WIRE)--Invivoscribe, a global leader in precision diagnostics and measurable residual disease more...
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Application submitted for manufacturing and marketing approval of ripretinib in Japan for the indication of “gastrointestinal stromal tumor that has progressed following cancer chemotherapy” Ripretinib has significantly prolonged the primary endpoint of progression-free survival compared more...
BostonGene Demonstrates Disease Modeling Platform at JSMO 2026, Advancing AI-Driven Drug Development and Precision Oncology
BostonGene highlights how its foundation models enable decision-making across drug development and clinical care, with growing adoption by leading biopharma partnersWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, more...
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
Terns’ lead candidate TERN-701 is an investigational oral allosteric BCR::ABL1 tyrosine kinase inhibitor currently in Phase 1/2 development for certain patients with CML Merck to hold investor call at 8 a.m. EDT todayRAHWAY, N.J., & more...
HELP USA, Camber Property Group & NYC Department of Social Services Open First-of-Its-Kind Intake Center for Women Entering the Homeless Shelter System
New 60,000-square-foot center is designed as a dedicated gateway for women entering shelter, supporting person-centered intake, assessment, and careBROOKLYN, N.Y.--(BUSINESS WIRE)--HELP USA, Camber Property Group, and the New York City Department of Social Services (DSS) more...
U.S. FDA Approves Label Update to Accelerate Thaw Time for ADSTILADRIN® (nadofaragene firadenovec-vncg)
Accelerated water-bath thawing, completed in about 25 minutes, may help streamline clinical workflows and support efficient patient management Label update includes data showing that product stability is maintained with the 25-minute, 25° C water-bath method more...
Phreesia Named One of Becker’s Top Places to Work in Healthcare
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named one of Becker’s Healthcare’s Top Places to Work in Healthcare for 2026. This marks Phreesia’s second time being included on more...
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call more...
Mark Farrah Associates’ Health Coverage Portal Simplifies Health Insurance Data Analytics
PITTSBURGH--(BUSINESS WIRE)--Mark Farrah Associates (MFA), a leading data aggregator and publisher of health plan market data and analytics, aggregates industry metrics from statutory financial statements filed with state insurance regulators in its Health Coverage Portal™ more...
Impact Podcast with John Shegerian Features Special Two-Part, In-Depth Interview with Dr. Dawn Mussallem
Healthy Living and Longevity Thought Leader Shares Her Personal Inspirational Survival StoryLOS ANGELES--(BUSINESS WIRE)--#cancer--Lifestyle medicine thought leader and Chief Medical Officer of Fountain Life Dr. Dawn Mussallem, DO, DipABLM, is the featured guest of a more...